← Leaderboards
James Jason McAnany
University Of Illinois At Chicago
$5,691,479
Attributed
$6,944,128
Total exposure
6
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $954.2K · FY2009–25$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,944,128 · 6
By mechanism
R01$5,677,398 · 2
R00$706,680 · 1
P30$398,360 · 2
K99$161,690 · 1
Top collaborators
- Neal S Peachey4 shared
- Botir T. Sagdullaev4 shared
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Kenneth R. Alexander$2,795,927
- Heather Elspeth Moss$3,684,596
- Olusola Ajilore$11,830,394
Others in their field
Top investigators on “Insight”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- James Dennis Neaton · Northwestern University$283,212,546
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$278,513,775
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
Research focus
InsightVisionFunctional DisorderPathway InteractionsElectroretinographyLightEye DiseasesResponseBaseVisualPatternElectrophysiology (Science)AffectRetinaSitePsychophysicsNovel Therapeutic InterventionContrast SensitivityRetinal DiseasesNoiseTherapeutic InterventionSignal TransductionInvestigationPrevent
Grant awards (23)
Mechanisms of Early Functional Loss in Diabetic Eye Disease$437,062
R01 · FY2025 · EY · contact PI
Translational Core for Therapeutic and Diagnostic Development$99,590
P30 · FY2025 · EY · contact PI
Translational Core for Therapeutic and Diagnostic Development$99,590
P30 · FY2024 · EY · contact PI
Mechanisms of Early Functional Loss in Diabetic Eye Disease$399,750
R01 · FY2023 · EY · contact PI
Mechanisms of Early Functional Loss in Diabetic Eye Disease$187,469
R01 · FY2023 · EY · contact PI
Translational Core for Therapeutic and Diagnostic Development$99,590
P30 · FY2023 · EY · contact PI
Mechanisms of Vision Loss in X-Linked Juvenile Retinoschisis$466,860
R01 · FY2022 · EY
Mechanisms of Early Functional Loss in Diabetic Eye Disease$387,758
R01 · FY2022 · EY · contact PI
Translational Core for Therapeutic and Diagnostic Development$99,590
P30 · FY2022 · EY · contact PI
Mechanisms of Vision Loss in X-Linked Juvenile Retinoschisis$466,860
R01 · FY2021 · EY
Mechanisms of Early Functional Loss in Diabetic Eye Disease$399,750
R01 · FY2021 · EY · contact PI
Mechanisms of Vision Loss in X-Linked Juvenile Retinoschisis$481,045
R01 · FY2020 · EY
Mechanisms of Early Functional Loss in Diabetic Eye Disease$399,750
R01 · FY2020 · EY · contact PI
Mechanisms of Vision Loss in X-Linked Juvenile Retinoschisis$464,208
R01 · FY2019 · EY
Mechanisms of Early Functional Loss in Diabetic Eye Disease$399,750
R01 · FY2019 · EY · contact PI
Mechanisms of Early Functional Loss in Diabetic Eye Disease$399,750
R01 · FY2018 · EY · contact PI
Mechanisms of Early Functional Loss in Diabetic Eye Disease$399,750
R01 · FY2017 · EY · contact PI
Mechanisms of Early Functional Loss in Diabetic Eye Disease$387,636
R01 · FY2016 · EY · contact PI
Mechanisms limiting visual performance in retinal degenerations$226,200
R00 · FY2013 · EY · contact PI
Mechanisms limiting visual performance in retinal degenerations$237,666
R00 · FY2012 · EY · contact PI
Mechanisms limiting visual performance in retinal degenerations$242,814
R00 · FY2011 · EY · contact PI
Mechanisms limiting visual performance in retinal degenerations$82,040
K99 · FY2010 · EY · contact PI
Mechanisms limiting visual performance in retinal degenerations$79,650
K99 · FY2009 · EY · contact PI